Preclinical CRO Treatment Market Demand, Size, Share & Forecast 2032

Preclinical CRO Treatment Market

Preclinical CRO Treatment Market - by Type (Pharmacokinetics/Pharmacodynamics (PK/PD), Early Phase Development Services, Toxicology Testing, Laboratory Services, Clinic Research Services, Stability Testing, Physical Characterization, Raw Material Testing, Batch Release Testing, And Analytical Testing And Other Consulting Services), by Therapeutic Area (CNS Disorders, Oncology, Cardiovascular Diseases, Infectious Diseases, Respiratory Disorders, Immunological Disorders, Diabetes, Others), by End-User (Medical Device Companies, Pharmaceutical And Biopharmaceutical Companies, And Academic Institutes), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast 2024 - 2032

Category: Medical Device Report Format : PDF Pages: 230 Report Code: ZMR-2887 Published Date: May-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 210.9 Million USD 9,350.60 Million 5.72% 2023

Table Of Content

  • Chapter 1 Preface
    • 1.1 Report Description
    • 1.1 Report Scope
  • Chapter 2 Research Methodology
    • 2.1 Research Methodology
    • 2.2 Secondary Research
    • 2.3 Primary Research
    • 2.4 Models
      • 2.4.1 Company Share Analysis Model
      • 2.4.2 Revenue Based Modelling
    • 2.5 Research Limitations
  • Chapter 3 Executive Summary
    • 3.1 Global Preclinical CRO Treatment Market, 2024 – 2032 (USD Million)
    • 3.2 Global Preclinical CRO Treatment Market: Snapshot
  • Chapter 4 Preclinical CRO Treatment Market – Industry Analysis
    • 4.1 Introduction
    • 4.2 Market Drivers
      • 4.2.1 Driving Factor 1 Analysis
      • 4.2.2 Driving Factor 2 Analysis:
    • 4.3 Market Restraints
      • 4.3.1 Restraining Factor Analysis
    • 4.4 Market Opportunities
      • 4.4.1 Market Opportunity & Use-case Analysis
      • 4.4.2 Use – Cases for Preclinical CRO Treatment
    • 4.5 Porter’s Five Forces Analysis
    • 4.6 COVID 19 Impact Analysis
      • 4.6.1.1 Impact on Product Development and Technology Adoption
      • 4.6.1.2 Gap Analysis
  • Chapter 5 Investment Proposition Analysis
    • 5.1 Global Preclinical CRO Treatment Market Attractiveness, By Type
    • 5.2 Global Preclinical CRO Treatment Market Attractiveness, By Therapeutic Area
    • 5.3 Global Preclinical CRO Treatment Market Attractiveness, By End-User
    • 5.4 Global Preclinical CRO Treatment Market Attractiveness, By Region
  • Chapter 6 Competitive Landscape
    • 6.1 Company Market Share Analysis - 2024
      • 6.1.1 Global Preclinical CRO Treatment Market: Company Market Share, 2024
    • 6.2 Strategic Developments
    • 7.1 Global Preclinical CRO Treatment Market Overview: By Type
      • 7.1.1 Global Preclinical CRO Treatment Market Revenue Share, By Type, 2024 & 2032
    • 7.2 Global Preclinical CRO Treatment Market Analysis/Overview – By Type
      • 7.2.1 Pharmacokinetics/Pharmacodynamics – Overview/Analysis
      • 7.2.2 Early Phase Development Services – Overview/Analysis
      • 7.2.3 Toxiculogy Testing – Overview/Analysis
      • 7.2.4 Laboratory Services – Overview/Analysis
      • 7.2.5 Clinic Research Services – Overview/Analysis
      • 7.2.6 Stability Testing – Overview/Analysis
      • 7.2.7 Physical Characterization – Overview/Analysis
      • 7.2.8 Raw Material Testing – Overview/Analysis
      • 7.2.9 Batch Release Testing – Overview/Analysis
      • 7.2.10 Other Services – Overview/Analysis
    • 7.3 Pharmacokinetics/Pharmacodynamics
      • 7.3.1 Global Preclinical CRO Treatment Market for Pharmacokinetics/Pharmacodynamics, Revenue (USD Million) 2024 - 2032
    • 7.4 Early Phase Development Services
      • 7.4.1 Global Preclinical CRO Treatment Market for Early Phase Development Services, Revenue (USD Million) 2024 - 2032
    • 7.5 Toxiculogy Testing
      • 7.5.1 Global Preclinical CRO Treatment Market for Toxiculogy Testing, Revenue (USD Million) 2024 - 2032
    • 7.6 Laboratory Services
      • 7.6.1 Global Preclinical CRO Treatment Market for Laboratory Services, Revenue (USD Million) 2024 - 2032
    • 7.7 Clinic Research Services
      • 7.7.1 Global Preclinical CRO Treatment Market for Clinic Research Services, Revenue (USD Million) 2024 - 2032
    • 7.8 Stability Testing
      • 7.8.1 Global Preclinical CRO Treatment Market for Stability Testing, Revenue (USD Million) 2024 - 2032
    • 7.9 Physical Characterization
      • 7.9.1 Global Preclinical CRO Treatment Market for Physical Characterization, Revenue (USD Million) 2024 - 2032
    • 7.10 Raw Material Testing
      • 7.10.1 Global Preclinical CRO Treatment Market for Raw Material Testing, Revenue (USD Million) 2024 - 2032
    • 7.11 Batch Release Testing
      • 7.11.1 Global Preclinical CRO Treatment Market for Batch Release Testing, Revenue (USD Million) 2024 - 2032
    • 7.12 Other Services
      • 7.12.1 Global Preclinical CRO Treatment Market for Other Services, Revenue (USD Million) 2024 - 2032
    • 8.1 Global Preclinical CRO Treatment Market Overview: By Therapeutic Area
      • 8.1.1 Global Preclinical CRO Treatment Market Revenue Share, By Therapeutic Area, 2024 & 2032
    • 8.2 Global Preclinical CRO Treatment Market Analysis/Overview – By Therapeutic Area
      • 8.2.1 CNS Disorders – Overview/Analysis
      • 8.2.2 Onculogy – Overview/Analysis
      • 8.2.3 Cardiovascular Diseases – Overview/Analysis
      • 8.2.4 Infectious Diseases – Overview/Analysis
      • 8.2.5 Respiratory Diseases – Overview/Analysis
      • 8.2.6 Immunulogical Diseases – Overview/Analysis
      • 8.2.7 Diabetes – Overview/Analysis
      • 8.2.8 Others – Overview/Analysis
    • 8.3 CNS Disorders
      • 8.3.1 Global Preclinical CRO Treatment Market for CNS Disorders, Revenue (USD Million) 2024 - 2032
    • 8.4 Onculogy
      • 8.4.1 Global Preclinical CRO Treatment Market for Onculogy, Revenue (USD Million) 2024 - 2032
    • 8.5 Cardiovascular Diseases
      • 8.5.1 Global Preclinical CRO Treatment Market for Cardiovascular Diseases, Revenue (USD Million) 2024 - 2032
    • 8.6 Infectious Diseases
      • 8.6.1 Global Preclinical CRO Treatment Market for Infectious Diseases, Revenue (USD Million) 2024 - 2032
    • 8.7 Respiratory Diseases
      • 8.7.1 Global Preclinical CRO Treatment Market for Respiratory Diseases, Revenue (USD Million) 2024 - 2032
    • 8.8 Immunulogical Diseases
      • 8.8.1 Global Preclinical CRO Treatment Market for Immunulogical Diseases, Revenue (USD Million) 2024 - 2032
    • 8.9 Diabetes
      • 8.9.1 Global Preclinical CRO Treatment Market for Diabetes, Revenue (USD Million) 2024 - 2032
    • 8.10 Others
      • 8.10.1 Global Preclinical CRO Treatment Market for Others, Revenue (USD Million) 2024 - 2032
    • 9.1 Global Preclinical CRO Treatment Market Overview: By End-User
      • 9.1.1 Global Preclinical CRO Treatment Market Revenue Share, By End-User, 2024 & 2032
    • 9.2 Global Preclinical CRO Treatment Market Analysis/Overview – By End-User
      • 9.2.1 Medical Device Companies – Overview/Analysis
      • 9.2.2 Pharmaceutical & Biopharmaceutical Companies – Overview/Analysis
      • 9.2.3 Academic Institutes – Overview/Analysis
    • 9.3 Medical Device Companies
      • 9.3.1 Global Preclinical CRO Treatment Market for Medical Device Companies, Revenue (USD Million) 2024 - 2032
    • 9.4 Pharmaceutical & Biopharmaceutical Companies
      • 9.4.1 Global Preclinical CRO Treatment Market for Pharmaceutical & Biopharmaceutical Companies, Revenue (USD Million) 2024 - 2032
    • 9.5 Academic Institutes
      • 9.5.1 Global Preclinical CRO Treatment Market for Academic Institutes, Revenue (USD Million) 2024 - 2032
  • Chapter 10 Preclinical CRO Treatment Market – Regional Analysis
    • 10.1 Global Preclinical CRO Treatment Market: Regional Overview
      • 10.1.1 Global Preclinical CRO Treatment Market Revenue Share, by Region, 2024 & 2032
      • 10.1.2 Global Preclinical CRO Treatment Market Revenue, by Region, 2024 – 2032 (USD Million)
    • 10.2 North America
      • 10.2.1 North America Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
      • 10.2.2 North America Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
      • 10.2.3 North America Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032
      • 10.2.4 North America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032
      • 10.2.5 North America Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032
      • 10.2.6 U.S.
      • 10.2.7 Canada
    • 10.3 Europe
      • 10.3.1 Europe Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
      • 10.3.2 Europe Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
      • 10.3.3 Europe Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032
      • 10.3.4 Europe Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032
      • 10.3.5 Europe Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032
      • 10.3.6 Germany
      • 10.3.7 France
      • 10.3.8 U.K.
      • 10.3.9 Rest of Europe
    • 10.4 Asia Pacific
      • 10.4.1 Asia Pacific Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
      • 10.4.2 Asia Pacific Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
      • 10.4.3 Asia Pacific Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032
      • 10.4.4 Asia Pacific Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032
      • 10.4.5 Asia Pacific Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032
      • 10.4.6 China
      • 10.4.7 Japan
      • 10.4.8 India
      • 10.4.9 Rest of Asia Pacific
    • 10.5 Latin America
      • 10.5.1 Latin America Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
      • 10.5.2 Latin America Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
      • 10.5.3 Latin America Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032
      • 10.5.4 Latin America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032
      • 10.5.5 Latin America Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032
      • 10.5.6 Brazil
      • 10.5.7 Rest of Latin America
    • 10.6 The Middle-East and Africa
      • 10.6.1 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
      • 10.6.2 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
      • 10.6.3 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032
      • 10.6.4 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032
      • 10.6.5 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032
      • 10.6.6 GCC Countries
      • 10.6.7 Rest of Middle-East Africa
  • Chapter 11 Company Profiles
    • 11.1 Paraxel International Corporation
      • 11.1.1 Company Overview
      • 11.1.2 Financial Overview
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 Laboratory Corporation of America
    • 11.3 Charles River Laboratories International, Inc.
    • 11.4 Eurofins Scientific
    • 11.5 Envigo
    • 11.6 Wuxi AppTec
    • 11.7 PRA Health Science, Inc.
    • 11.8 Pharmaceutical Product Development, LLC.
    • 11.9 Medpace, Inc.

Table Of Figures

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Preclinical CRO Treatment Market
FIG. 6 Global Preclinical CRO Treatment Market Attractiveness, By Type
FIG. 7 Global Preclinical CRO Treatment Market Attractiveness, By Therapeutic Area
FIG. 8 Global Preclinical CRO Treatment Market Attractiveness, By End-User
FIG. 9 Global Preclinical CRO Treatment Market Attractiveness, By End-User
FIG. 10 Company Share Analysis, 2024
FIG. 11 Global Preclinical CRO Treatment Market Revenue Share, By Type, 2024 & 2032
FIG. 12 Global Preclinical CRO Treatment Market for Pharmacokinetics/Pharmacodynamics, Revenue (USD Million) 2024 - 2032
FIG. 13 Global Preclinical CRO Treatment Market for Early Phase Development Services, Revenue (USD Million) 2024 - 2032
FIG. 14 Global Preclinical CRO Treatment Market for Toxicology Testing, Revenue (USD Million) 2024 - 2032
FIG. 15 Global Preclinical CRO Treatment Market for Laboratory Services, Revenue (USD Million) 2024 - 2032
FIG. 16 Global Preclinical CRO Treatment Market for Clinic Research Services, Revenue (USD Million) 2024 - 2032
FIG. 17 Global Preclinical CRO Treatment Market for Stability Testing, Revenue (USD Million) 2024 - 2032
FIG. 18 Global Preclinical CRO Treatment Market for Physical Characterization, Revenue (USD Million) 2024 - 2032
FIG. 19 Global Preclinical CRO Treatment Market for Raw Material Testing, Revenue (USD Million) 2024 - 2032
FIG. 20 Global Preclinical CRO Treatment Market for Batch Release Testing, Revenue (USD Million) 2024 - 2032
FIG. 21 Global Preclinical CRO Treatment Market for Other Services, Revenue (USD Million) 2024 - 2032
FIG. 22 Global Preclinical CRO Treatment Market Revenue Share, By Therapeutic Area, 2024 & 2032
FIG. 23 Global Preclinical CRO Treatment Market for CNS Disorders, Revenue (USD Million) 2024 - 2032
FIG. 24 Global Preclinical CRO Treatment Market for Oncology, Revenue (USD Million) 2024 - 2032
FIG. 25 Global Preclinical CRO Treatment Market for Cardiovascular Diseases, Revenue (USD Million) 2024 - 2032
FIG. 26 Global Preclinical CRO Treatment Market for Infectious Diseases, Revenue (USD Million) 2024 - 2032
FIG. 27 Global Preclinical CRO Treatment Market for Respiratory Diseases, Revenue (USD Million) 2024 - 2032
FIG. 28 Global Preclinical CRO Treatment Market for Immunological Diseases, Revenue (USD Million) 2024 - 2032
FIG. 29 Global Preclinical CRO Treatment Market for Diabetes, Revenue (USD Million) 2024 - 2032
FIG. 30 Global Preclinical CRO Treatment Market for Others, Revenue (USD Million) 2024 - 2032
FIG. 31 Global Preclinical CRO Treatment Market Revenue Share, By End-User, 2024 & 2032
FIG. 32 Global Preclinical CRO Treatment Market for Medical Device Companies, Revenue (USD Million) 2024 - 2032
FIG. 33 Global Preclinical CRO Treatment Market for Pharmaceutical & Biopharmaceutical Companies, Revenue (USD Million) 2024 - 2032
FIG. 34 Global Preclinical CRO Treatment Market for Academic Institutes, Revenue (USD Million) 2024 - 2032
FIG. 35 Global Preclinical CRO Treatment Market Revenue Share, by Region, 2024 & 2032
FIG. 36 North America Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 37 Europe Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 38 Asia Pacific Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 39 Latin America Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 40 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, 2024 - 2032 (USD Million)
FIG. 41 Paraxel International Corporation Business Segment Revenue Share, 2024 (%)
FIG. 42 Paraxel International Corporation Geographical Segment Revenue Share, 2024 (%)
 


Table Of Tables

List of Tables

TABLE 1 Global Preclinical CRO Treatment Market: Snapshot
TABLE 2 Drivers of the Preclinical CRO Treatment Market: Impact Analysis
TABLE 3 Restraints for the Preclinical CRO Treatment Market: Impact Analysis
TABLE 4 Global Preclinical CRO Treatment Market Revenue, by Region, 2024 – 2032 (USD Million)
TABLE 5 North America Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 6 North America Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032 (USD Million)
TABLE 7 North America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million)
TABLE 8 North America Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032 (USD Million)
TABLE 9 Europe Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 10 Europe Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032 (USD Million)
TABLE 11 Europe Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million)
TABLE 12 Europe Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032 (USD Million)
TABLE 13 Asia Pacific Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 14 Asia Pacific Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032 (USD Million)
TABLE 15 Asia Pacific Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million)
TABLE 16 Asia Pacific Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032 (USD Million)
TABLE 17 Latin America Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 18 Latin America Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032 (USD Million)
TABLE 19 Latin America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million)
TABLE 20 Latin America Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032 (USD Million)
TABLE 21 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, by Country, 2024 – 2032 (USD Million)
TABLE 22 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Type, 2024 – 2032 (USD Million)
TABLE 23 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million)
TABLE 24 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By End-User, 2024 – 2032 (USD Million)

Methodology

FrequentlyAsked Questions

A preclinical CRO treatment refers to a service provided by a Contract Research Organization (CRO) to perform tests on substances (potential drugs) in cells or animals before human trials can begin.

According to a study, the global preclinical CRO treatment market size was worth around USD 210.9 million in 2023 and is expected to reach USD 9,350.60 million by 2032.
 

The global preclinical CRO treatment market is expected to grow at a CAGR of 5.72% during the forecast period.
 

North America is expected to dominate the preclinical CRO treatment market over the forecast period.
 

Leading players in the global preclinical CRO treatment market include Paraxel International Corporation, Laboratory Corporation of America, Charles River Laboratories International, Inc., Eurofins Scientific, Envigo, Wuxi AppTec, PRA Health Science, Inc., Pharmaceutical Product Development, LLC., and Medpace, Inc., among others.
 

The preclinical CRO treatment market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

Choose License Type

  • zion payment modes

List of Contents

Industry PerspectiveOverviewReport ScopeCompetitive Analysis

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed